Jamie Dimon’s Crack at Shadowy Proxy Firms Is Resonating

Pressure is again mounting on the proxy advisory firms that recommend how investors should vote on executive pay and other corporate matters. Regulators need to remember who should be prioritized here — investors, not company management.

The corporate sector has an enduring complaint that this niche industry, which is dominated by Institutional Shareholder Services Inc. and Glass Lewis & Co., is too opaque and too powerful. In 2022, the US Securities and Exchange Commission scrapped tighter regulation on proxy advisers. Now the debate is creeping into the UK regulatory conversation, with the British governance watchdog this week flagging plans for greater scrutiny.

April’s annual shareholder letter from JPMorgan Chase & Co. boss Jamie Dimon sums up the concerns of the C-suite. A longstanding proxy critic, he portrays an investment ecosystem where voting decisions are made by asset managers’ so-called stewardship committees without heeding the investment professionals who run the funds. These committees blindly follow proxy adviser recommendations based on information that’s frequently “not representative of the full view and not accurate,” Dimon goes on. To cap it all, corporates struggle to get errors corrected. In sum, he says these advisers have “undue influence.”

In the same month, amid frowning at a proposed pay bump for AstraZeneca Plc Chief Executive Officer Pascal Soriot, the drugmaker’s chairman wrote that proxy advisers’ “double standards” on pay did “serious harm” to UK corporate competitiveness. Research by Durham University and consultant Morrow Sodali published last year found that some UK companies reckoned proxy advisers were box-tickers ignorant of corporations’ freedom to disregard governance best practice so long as they explained why.